DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Asparaginase

Asparaginase

  • Treatment of Localized Extranodal NK/T Cell Lymphoma, Nasal Type: a Systematic Review Seok Jin Kim†, Sang Eun Yoon† and Won Seog Kim*

    Treatment of Localized Extranodal NK/T Cell Lymphoma, Nasal Type: a Systematic Review Seok Jin Kim†, Sang Eun Yoon† and Won Seog Kim*

  • Ciera L. Patzke, Alison P. Duffy, Vu H. Duong, Firas El Chaer 4, James A

    Ciera L. Patzke, Alison P. Duffy, Vu H. Duong, Firas El Chaer 4, James A

  • Asparaginase As Consolidation Therapy in Patients Undergoing Bone Marrow Transplantation for Acute Lymphoblastic Leukemia

    Asparaginase As Consolidation Therapy in Patients Undergoing Bone Marrow Transplantation for Acute Lymphoblastic Leukemia

  • Prescribing Information | VELCADE® (Bortezomib)

    Prescribing Information | VELCADE® (Bortezomib)

  • Acute Lymphoblastic Leukemia (ALL) (Part 1 Of

    Acute Lymphoblastic Leukemia (ALL) (Part 1 Of

  • L-Asparaginase-Induced Hepatotoxicity Treated Successfully with L-Carnitine and Vitamin B Infusion

    L-Asparaginase-Induced Hepatotoxicity Treated Successfully with L-Carnitine and Vitamin B Infusion

  • Cancer Drug Costs for a Month of Treatment at Initial Food and Drug

    Cancer Drug Costs for a Month of Treatment at Initial Food and Drug

  • Erwinaze® (Asparaginase Erwinia Chrysanthemi) (Intramuscular/Intravenous)

    Erwinaze® (Asparaginase Erwinia Chrysanthemi) (Intramuscular/Intravenous)

  • CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS

    CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS

  • Overview of the Current Treatment Strategy in Extranodal NK/T-Cell Lymphoma: from Diagnosis to Recurrence

    Overview of the Current Treatment Strategy in Extranodal NK/T-Cell Lymphoma: from Diagnosis to Recurrence

  • Protocol, L-Asparaginase, Cisplatin, Dexamethasone

    Protocol, L-Asparaginase, Cisplatin, Dexamethasone

  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021

    FDA Listing of Established Pharmacologic Class Text Phrases January 2021

  • Activity of Bortezomib in Glioblastoma

    Activity of Bortezomib in Glioblastoma

  • NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

    NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

  • Asparaginase

    Asparaginase

  • 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs

    2012 NIOSH List of Antineoplastic and Other Hazardous Drugs

  • Product Monograph

    Product Monograph

  • Dose Intensification of Methotrexate and Cytarabine During

    Dose Intensification of Methotrexate and Cytarabine During

Top View
  • Chemotherapy Extravasation Management
  • Cytarabine Injection for Intravenous, Intrathecal and Subcutaneous Use Only
  • The Effect of Asparaginase Therapy on Methotrexate Toxicity and Efficacy in Children with Acute Lymphoblastic Leukemia
  • Combination Chemotherapy in Vitro Exploiting Glutamine Metabolism of Human Glioma and Medulloblastoma1
  • How to Order Chemotherapy at Shands at the University of Florida - Inpatient
  • Recent Strategies and Applications for L-Asparaginase Confinement
  • Asparaginase (Elspar)
  • Direct Long-Term Effects of L-Asparaginase on Rat and Human Pancreatic Islets
  • Pharmacokinetic Modeling of an Induction Regimen for in Vivo Combined Testing of Novel Drugs Against Pediatric Acute Lymphoblastic Leukemia Xenografts
  • Suppression of Murine Leukemias by I
  • Longitudinal Trends in Use and Costs of Targeted Therapies for Common Cancers in Taiwan: a Retrospective Observational Study
  • Chemotherapy Side Effects.Pdf
  • Individualized Dosing Guidelines for Pegasparaginase
  • Phase I Dose Escalating Study of Oral Cyclophosphamide in Tumour
  • Combination Effect of Antitumor Agents, Including Doxorubicin
  • Photodynamic Therapy Combined with Bcl-2/Bcl-Xl Inhibition Increases the Noxa/Mcl-1 Ratio Independent of Usp9x and Synergistically Enhances Apoptosis in Glioblastoma
  • PRODUCTION and OPTIMIZATION of L-ASPARAGINASE from Pseudomonas Aeruginosa by STRAIN IMPROVEMENT
  • Pharmacist Involvement in the Management of Adverse Effects


© 2024 Docslib.org    Feedback